Effect of fortification with powder nutrients in prevention and treatment of nutrient deficiency
Not Applicable
Recruiting
- Conditions
- Deficiency DiseasesIron deficiency anemiaVitamin A DeficiencyHearing lossAnemiaC15.378.071C18.654.521.500.133.628C15.378.071.196.300C18.654.521.500C09.218.458.341
- Registration Number
- RBR-4hm7mz
- Lead Sponsor
- Faculdade de Nutrição da Universidade Federal de Goiás
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Children aged six to 48 months; anemic and non-anemic.
Exclusion Criteria
Children in treatment of anemia; malaria; HIV, hemoglobinopathies or hemochromatosis; low weight at birth; preterm birth (less than 37 weeks); twin; allergies reported to any components of the fortification sachet and/or to ferrous sulfate/folic acid.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome will be the difference in mean serum hemoglobin levels, <br>verified by electronic counting, between children receiving Nutrisus or supplementation with iron and folic acid, measured before and after the intervention.<br>
- Secondary Outcome Measures
Name Time Method Presence or absence of rs855791 polymorphism in the TMPRSS6 gene. Genotyping will be performed by real-time polymerase chain reaction (qPCR) using the inventoried assay (TaqMan® SNP Genotyping Assays, Waltham, Massachusetts, USA) for SNPs rs855791 located in the TMPRSS6 gene, which encodes a transmembrane serine protease 6. StepOne equipment will be used (Thermo Fisher Scientific, Massachusetts, USA).;Any change in serum vitamin A, verified by High Performance Liquid Chromatography (HPLC), measured before and after the intervention.;Any change in serum vitamin E, verified by High Performance Liquid Chromatography (HPLC), measured before and after the intervention.;Any change in serum vitamin D, <br>verified by amplified chemiluminescence, measured before and after the intervention.;Any change in serum folic acid level, verified by commercial fluoroimmunoassays, measured before and after the intervention.